Testing effectiveness (Phase 2)Active Not RecruitingNCT03284385
What this trial is testing
Testing AZD1775 in Advanced Solid Tumors That Have a Mutation Called SETD2
Who this might be right for
Clear Cell Renal Cell CarcinomaLocally Advanced Clear Cell Renal Cell CarcinomaLocally Advanced Malignant Solid Neoplasm+4 more
National Cancer Institute (NCI) 60